Skip to content

Clinical trials

Phase 3 Dyslipidemias trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dyslipidemias Phase: Phase 3 Clear all

191 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20014
20026
200312
20048
200513
200627
200715
200811
20095
20101
20118
20124
20136
20145
20154
20168
20175
20186
20195
202114
20223
20234
20246
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed137
Terminated23
Unknown status12
Recruiting9
Withdrawn6
Active, not recruiting4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Takeda31
AstraZeneca13
Kowa Research Europe9
Abbott8
Amgen7
Merck Sharp & Dohme LLC7
EMS5
Novartis Pharmaceuticals5
Daewoong Pharmaceutical Co. LTD.4
JW Pharmaceutical4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dyslipidemias191
Hypercholesterolemia46
Diabetes Mellitus, Type 242
Diabetes Mellitus33
Glucose Metabolism Disorders29
Hyperlipidemias29
Hypertension23
Diabetes Mellitus, Lipoatrophic16
Obesity16
Cardiovascular Diseases14

Trials

Showing 26 to 50 of 191. Each trial links to its page on Pharma Observatory.

91 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.